ArticleSensors (Basel, Switzerland)2009

Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity.

Marco Rusnati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.